Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database.

James M WrightTiffany R HodgesChristina Huang WrightHaley GittlemanXiaofei ZhouKelsey DuncanCarol KruchkoAndrew SloanJill S Barnholtz-Sloan

Published in: Journal of neuro-oncology (2019)

Race/ethnicity are not associated with differences in overall survival, 30-day mortality, 90-day mortality, or 30-day readmission following surgical intervention for gliosarcoma.

Keyphrases

cardiovascular events
randomized controlled trial
free survival
risk factors
type diabetes
emergency department
cardiovascular disease
adverse drug